ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1 -Mutant Breast Cancer is a research paper published in Cancer Discovery (2023). On theSindex it has a DataRank of 0. It has been cited 38 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cancer Research UK
Grant: CRUK/15/010
Cancer Research UK
Grant: C30746/A19505
National Institute for Health Research (NIHR)
Grant: NIHR202432
NCI NIH HHS
Grant: P50 CA247749
NCI NIH HHS
Grant: R01 CA234361
NCI NIH HHS
Grant: R01 CA245069
NCI NIH HHS
Grant: R01 CA220284
Cancer Research UK
Grant: 19505
NCI NIH HHS
Grant: P30 CA008748
National Institutes of Health
Grant: 5R01CA245069-05
Defining the impact of mutant oncogene zygosity
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 6R01CA220284-05
Chemical, structural and molecular rules for fully antagonizing the estrogen receptor
Breast Cancer Now
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
FWCI
8.40
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals